Skip to content

CannIbite

Active Private limited company (pre-2019)founded 2014active for 12 yearsGroeningenlei 144, 2550 KontichKBO/BCE: BE 0560.771.945

Lifetime

11 annual accounts with figures on one time axis
peak of €293,556 in 2019
€60,311▼ 60.3%
lowest -€144,231 in 2021
€84,489▼ 43.4%
peak of €308,292 in 2019
€157,870▲ 115%
€346,052▼ 19.5%
peak of 2.8 FTE in 2015
-not published
Board1 name since 2025
1 director
Documentsfilings and deeds
31-07-2026on the last day
2025abbreviated format
Gross margin from €151,798 to €60,311Result from €149,152 to €84,489Registered office moved from Antwerp to Kontich 21-11Equity from €73,381 to €157,870Debts from €430,145 to €346,052

Key points

from the 2025 annual accounts

Equity

€157,870 ▲ 115%
€73,4002024€158,0002025

Equity rose in 2025 from €73,381 to €157,870.

Liquidity

8.36 was 1.19 in 2024

Short-term debts fell from €414,915 to €59,004.

Filings

11 annual accounts since 2015
AprilJune31 JulyOctober201520202025

Eight of the last ten came late. The 2019 accounts came in latest, 122 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,817 companies had the same profile as CannIbite has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,817 companies, not a prediction for CannIbite. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, , since 27-06-2025
  • founderdeed of 29-08-2014
Board & ownership

Recent changes

Registered office moved from Antwerp to Kontich The registered office moved from Rijnkaai 36, 2000 Antwerpen to Groeningenlei 144 bus 04, 2550 Kontich · resigns as director · appointed as director · General meeting of 27-06-2025 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0560771945
Company renamed from EURO DENT BELGIË to CannIBite Registered office moved within Mortsel · The registered office moved from Prins Leopoldlei 8-10, 2640 Mortsel to Prins Leopoldlei 12, 2640 Mortsel · “De studie, het onderzoek, het ontwerp, de analyse, de beschouwing, de farmacodynamie, de productie, de…” (deed in Dutch) · General meeting of 14-06-2019 · Gazette deed
Incorporation Founding capital of €50,000 · Founded by (partner and founder) · appointed as manager · published on 29-08-2014 · Gazette deed
All 25 events

Comparable companies

same main activity, similar in size and age
Company
CannIbite Kontich €503,922 €60,311 31.3% -
LB&K Sprimont €394,560 €50,328 97.6% -
Ergotrics Turnhout €376,384 €31,930 -86.6% -
CERTOR Mechelen €505,224 €101,531 96.3% -
Dokter Sara Van Soom, huisarts Edegem €477,219 €187,919 8.9% -
Oblita Therapeutics Zoersel €418,521 €112,473 7.9% -
SEMAPHAR Jodoigne €579,404 €154,902 34.2% -

These companies have the same main activity as CannIbite: research and development on biotechnology (NACE 72101). They are comparable in size and age: total assets between €376,000 and €579,000, founded between 2010 and 2015.

Official details

Source: KBO
Status
Active since 27-08-2014Normal situation
Registered office
15 active companies are registered at this addressOf these, 1 started in the 12 months before 20 November 2026. Source: KBO register, as of 20 November 2026.
Activity
Research and development on biotechnologyNACE 72101and 2 others
Establishment unit
2.234.252.5672550 Kontich, registered on 27-08-2014
Financial year end
31 December
Peppol
Reachable since 17-04-2025
Company details

Annual accounts 2025

≈ €180,000estimated
€503,922▲ 0.1%
Filing
Filed on 31-07-2026, on the last day of the filing period
Financials

Insights on CannIbite

CannIbite files the abbreviated format. That format states no turnover. The gross margin fell from €75,819 in 2015 to €60,311 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about CannIbite

What is the company number of CannIbite?
The company number of CannIbite is 0560.771.945. The VAT number is the same number with BE in front: BE 0560.771.945.
Where is CannIbite based?
The registered office is at Groeningenlei 144, 2550 Kontich.Company details
What does CannIbite do?
According to the KBO register, the main activity is research and development on biotechnology (NACE 72101).
What is the legal form of CannIbite?
CannIbite is a private limited company (pre-2019) (BVBA).
When was CannIbite founded?
CannIbite was founded on 27-08-2014.
Is CannIbite still active?
Yes, CannIbite is an active enterprise in the KBO register.
How many employees does CannIbite have?
CannIbite had an average of 0.8 full-time equivalents in financial year 2018, according to the filed annual accounts.Financials
What is the turnover of CannIbite?
The turnover in financial year 2025 is about €180,000. This figure is estimated from the gross margin of €60,311 and 992 comparable companies of the same size. It probably lies between €100,000 and €350,000. It is a rough estimate.
Is CannIbite profitable?
In financial year 2025, CannIbite made a profit of €84,489.
Where can I find the annual accounts of CannIbite?
CannIbite filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of CannIbite due?
CannIbite must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.